IART - Arcutis Announces Positive Data And Other News: The Good Bad And Ugly Of Biopharma October, 02 2020 05:21 AM Integra LifeSciences Holdings Corporation Arcutis receives a boost with positive seborrheic dermatitis study data. Integra LifeSciences to divest extremity orthopedics business. Alnylam announces positive data from Phase Lumasiran. For further details see: Arcutis Announces Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma